In this study 32 patients whom had only one superficial bladder tumor (T?-T1 stage) were selected to investigate the effectiveness of either BCG of Alfa-Interferon in preventing the recurrence of tumor.
Ghazimoghadam B (MD), Jabalameli P (MD)
doaj
Symptom burden and quality of life in patients with high-risk essential thrombocythaemia and polycythaemia vera receiving hydroxyurea or pegylated interferon alfa-2a: a post-hoc analysis of the MPN-RC 111 and 112 trials. [PDF]
Mazza GL +8 more
europepmc +1 more source
The regression time of ocular surface squamous neoplasia using topical interferon alfa-2b does not depend on the initial tumor size. [PDF]
Vilaltella M, Huerva V.
europepmc +1 more source
Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature. [PDF]
How J, Hobbs G.
europepmc +1 more source
The A150V Polymorphism of Genotype 3 Hepatitis C Virus Polymerase Inhibits Interferon Alfa by Suppressing Protein Kinase R Activation. [PDF]
Lee WJ +4 more
europepmc +1 more source
Hepatitis C, interferon alfa, and depression [PDF]
D, Zdilar +4 more
openaire +2 more sources
Authors' Response: Posterior subtenon interferon alfa-2B injection in inflammatory macular edema. [PDF]
Kawali A +3 more
europepmc +1 more source
Corrigendum to "Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study" [International Journal of Infectious Diseases, Volume 105, April 2021, Pages 516-521]. [PDF]
Pandit A +6 more
europepmc +1 more source

